Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fernando Valderrábano is active.

Publication


Featured researches published by Fernando Valderrábano.


Quality of Life Research | 2005

Psychosocial Factors and Health-Related Quality of Life in Hemodialysis Patients

Isabel Vázquez; Fernando Valderrábano; Joan Fort; Rosa Jofre; Juan M. López-Gómez; Fuensanta Moreno; Dámaso Sanz-Guajardo

Several sociodemographic and clinical variables are known to influence the health-related quality of life (HRQOL) of patients with kidney disease, yet the relationship between psychological factors and the HRQOL measured by the Kidney Disease Quality of Life Short-Form (KDQOL-SF) is incompletely understood. The objective of this study was to examine the relationship between psychosocial status (depressive symptoms, trait anxiety, and social support) and KDQOL-SF scales in hemodialysis (HD) patients by controlling the effects of sociodemographic and clinical variables. The HRQOL of 194 patients from 43 dialysis centers in Spain was assessed by completing the KDQOL-SF, and evaluating depressive symptoms (Cognitive Depression Index), trait anxiety (Trait Anxiety Inventory) and degree of social support (Scale of Perceived Social Support). We also recorded several sociodemographic and clinical variables. Two regression models were estimated for each of the 19 scales in the KDQOL-SF. In the first model, we only included sociodemographic and clinical-factors, while the second model also took into consideration psychosocial variables. These last factors (trait anxiety and depressive symptoms, not social support) were found to increase the proportion of explained variability, with highest standardized regression coefficients observed for most KDQOL-SF scales. Depressive symptoms were related to a poor HRQOL when there was a strong physical component, while trait anxiety was mainly related to emotional upset and social relationships. We were able to conclude that trait anxiety and depressive symptoms are strongly associated with the HRQOL assessed by the KDQOL-SF in HD patients. The effects of these factors should therefore be considered when evaluating the quality of life of this type of patient.


American Journal of Kidney Diseases | 2002

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey; Josef Coresh; Kline Bolton; Bruce F. Culleton; Kathy Schiro Harvey; T. Alp Ikizler; Cynda Ann Johnson; Annamaria T. Kausz; Paul L. Kimmel; John W. Kusek; Adeera Levin; Kenneth L. Minaker; Robert G. Nelson; Helmut Rennke; Michael Steffes; Beth Witten; Ronald J. Hogg; Susan Furth; Kevin V. Lemley; Ronald J. Portman; George Schwartz; Joseph Lau; Ethan M Balk; Ronald D. Perrone; Tauqeer Karim; Lara Rayan; Inas Al-Massry; Priscilla Chew; Brad C. Astor; Deirdre De Vine


American Journal of Kidney Diseases | 2001

Quality of life in end-stage renal disease patients.

Fernando Valderrábano; Rosa Jofre; Juan M. López-Gómez


American Journal of Kidney Diseases | 2002

K/DOQI clinical practice guidelines for chronic kidney disease

Andrew S. Levey; Josef Coresh; Kline Bolton; Bruce F. Culleton; Kathy Schiro Harvey; T. Alp Ikizler; Cynda Ann Johnson; Annamaria T. Kausz; Paul L. Kimmel; John W. Kusek; Adeera Levin; Kenneth L. Minaker; Robert G. Nelson; Helmut G. Rennke; Michael W. Steffes; Beth Witten; Ronald J. Hogg; Susan L. Furth; Kevin V. Lemley; Ronald J. Portman; George J. Schwartz; Joseph Lau; Ethan M Balk; Ronald D. Perrone; Tauqeer Karim; Lara Rayan; Inas Al-Massry; Priscilla Chew; Brad C. Astor; Deirdre De Vine


Nephrology Dialysis Transplantation | 2003

PRE‐dialysis survey on anaemia management

Fernando Valderrábano; Walter H. Hörl; Iain C. Macdougall; Jerome Rossert; Bolesław Rutkowski; Jean-Pierre Wauters


Kidney International | 2005

Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL.

Juan Carlos Ayus; Alan S. Go; Fernando Valderrábano; Eduardo Verde; Soledad García de Vinuesa; Steven G. Achinger; Victor Lorenzo; Allen I. Arieff; Jose Luao


American Journal of Kidney Diseases | 2003

Predialysis survey on anemia management: Patient referral★★★

Walter H. Hörl; Iain C. Macdougall; Jerome Rossert; Bolesław Rutkowski; Jean-Pierre Wauters; Fernando Valderrábano


Nephrology Dialysis Transplantation | 2001

Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis

Marian Goicoechea; Carlos Caramelo; Patrocinio Rodriguez; Eduardo Verde; Enrique Gruss; Marta Albalate; Alberto Ortiz; Santos Casado; Fernando Valderrábano


Nephrology Dialysis Transplantation | 2001

Haemodialysis dose, extracellular volume control and arterial hypertension

Rafael Pérez-García; Juan M. López-Gómez; Rosa Jofre; Eduardo Junco; Fernando Valderrábano


Nephrology Dialysis Transplantation | 1995

rHuEpo before dialysis and in dialysed patients

Juan M. López-Gómez; Rosa Jofre; F. Moreno; Eduardo Verde; Fernando Valderrábano

Collaboration


Dive into the Fernando Valderrábano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brad C. Astor

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John W. Kusek

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge